Arash Malakian Selected Research

Patent Ductus Arteriosus

1/2016

Effectiveness of intratracheal salbutamol in addition to surfactant on the clinical course of newborns with respiratory distress syndrome: a clinical trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Arash Malakian Research Topics

Disease

3	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2021 - 01/2016
2	Lung Diseases (Lung Disease) 01/2021 - 08/2020
2	Disease Progression 11/2018 - 01/2016
1	Neonatal Sepsis 04/2024
1	Sepsis (Septicemia) 04/2024
1	Lung Injury 01/2021
1	Transient Tachypnea of the Newborn 11/2018
1	Pneumothorax 01/2016
1	Patent Ductus Arteriosus 01/2016

Drug/Important Bio-Agent (IBA)

2	Surface-Active Agents (Surfactants)IBA 01/2021 - 01/2016
2	Albuterol (Salbutamol)FDA LinkGeneric 11/2018 - 01/2016
1	AmpC beta-lactamasesIBA 04/2024
1	beta-Lactamases (beta-Lactamase)IBA 04/2024
1	EnzymesIBA 04/2024
1	Oxygen (Dioxygen)IBA 01/2016

Therapy/Procedure

3	Artificial Respiration (Mechanical Ventilation) 01/2021 - 01/2016
2	Continuous Positive Airway Pressure 01/2021 - 08/2020
1	High-Frequency Ventilation 08/2020
1	Noninvasive Ventilation 08/2020
1	Therapeutics 01/2016